Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals

Diabetologia

Volumn 44, Issue 10, 2001, Pages 1268-1273

  Fisher, R M ^a   Eriksson, P ^a   Hoffstedt, J ^b   Hotamisligil, G S ^c   Thorne A ^b   Ryden M ^b   Hamsten, A ^a   Arner, P ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adipocyte; Adipocyte lipid binding protein; Fatty acid; Keratinocyte lipid binding protein; Obesity

Indexed keywords

ADIPOCYTE LIPID BINDING PROTEIN; BINDING PROTEIN; FATTY ACID BINDING PROTEIN; KERATINOCYTE LIPID BINDING PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; HUMAN; LIPID STORAGE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT;

ACTINS; ADIPOSE TISSUE; ADULT; BIOPSY; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARRIER PROTEINS; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OBESITY; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 0034770707     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100643     Document Type: Article

References (20)

1. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases?
2. Physiological properties and functions of intracellular fatty acid-binding proteins
3. Lipid-binding proteins modulate ligand-dependent trans-activation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm
4. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels
5. -/- mice
6. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein
7. Differences in lipolysis between human subcutaneous and omental adipose tissues
8. Regional adiposity and morbidity
9. Catecholamine-induced lipolysis in obesity
10. Leptin secretion from subcutaneous and visceral adipose tissue in women
11. Human adipocyte lipid-binding protein: Purification of the protein and cloning of its complementary DNA
12. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is similar to fatty acid-binding proteins
13. Improved glucose and lipid metabolism in genetically obese mice lacking aP2
14. Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein
15. Biochemical and biophysical analysis of the intracellular lipid binding proteins of adipocytes
16. Cell size regulation, a mechanism that controls cellular RNA accumulation: Consequences on regulation of the ubiquitous transcription factors Oct1 and NF-Y, and the liver-enriched transcription factor DPB
17. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals
18. -/-) mice after short-term high-fat feeding. Functional compensation by the keratinocyte fatty acid binding protein
19. Surface properties of adipocyte lipid-binding protein: Response to lipid binding, and comparison with homologous proteins
20. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation